Aehr Gross Profit vs Free Cash Flow per Share Analysis
AEHR Stock | USD 11.07 0.51 4.83% |
Aehr Test financial indicator trend analysis is way more than just evaluating Aehr Test Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aehr Test Systems is a good investment. Please check the relationship between Aehr Test Gross Profit and its Free Cash Flow Per Share accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Gross Profit vs Free Cash Flow Per Share
Gross Profit vs Free Cash Flow per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aehr Test Systems Gross Profit account and Free Cash Flow per Share. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Aehr Test's Gross Profit and Free Cash Flow per Share is 0.83. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Free Cash Flow per Share in the same time period over historical financial statements of Aehr Test Systems, assuming nothing else is changed. The correlation between historical values of Aehr Test's Gross Profit and Free Cash Flow per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Aehr Test Systems are associated (or correlated) with its Free Cash Flow per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow per Share has no effect on the direction of Gross Profit i.e., Aehr Test's Gross Profit and Free Cash Flow per Share go up and down completely randomly.
Correlation Coefficient | 0.83 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Aehr Test Systems minus its cost of goods sold. It is profit before Aehr Test operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Most indicators from Aehr Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aehr Test Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. At this time, Aehr Test's Tax Provision is relatively stable compared to the past year. As of 04/24/2024, Enterprise Value Over EBITDA is likely to grow to 63.14, while Selling General Administrative is likely to drop slightly above 8.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 23.7M | 32.7M | 37.7M | 39.5M | Total Revenue | 50.8M | 65.0M | 74.7M | 78.4M |
Aehr Test fundamental ratios Correlations
Click cells to compare fundamentals
Aehr Test Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aehr Test fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.6M | 21.7M | 62.3M | 98.1M | 112.9M | 118.5M | |
Other Current Liab | 1.4M | 2.2M | 3.6M | 4.1M | 3.7M | 1.9M | |
Total Current Liabilities | 3.9M | 9.1M | 11.0M | 16.3M | 18.8M | 19.7M | |
Total Stockholder Equity | 14.1M | 11.4M | 51.0M | 75.6M | 68.0M | 71.4M | |
Property Plant And Equipment Net | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Debt | (1.5M) | 241K | (30.5M) | (23.8M) | (21.4M) | (20.3M) | |
Retained Earnings | (74.3M) | (76.3M) | (66.9M) | (52.3M) | (47.1M) | (49.4M) | |
Accounts Payable | 945K | 2.9M | 4.2M | 9.2M | 10.6M | 11.1M | |
Cash | 5.4M | 4.6M | 31.5M | 30.1M | 34.6M | 36.3M | |
Non Current Assets Total | 2.9M | 2.5M | 2.3M | 9.1M | 8.2M | 8.6M | |
Non Currrent Assets Other | 73K | 118K | 121K | 81K | 72.9K | 69.3K | |
Cash And Short Term Investments | 5.4M | 4.6M | 31.5M | 47.9M | 55.1M | 57.8M | |
Net Receivables | 3.7M | 5.2M | 12.9M | 16.6M | 19.1M | 20.0M | |
Common Stock Shares Outstanding | 22.9M | 23.5M | 27.8M | 29.2M | 33.6M | 35.3M | |
Liabilities And Stockholders Equity | 20.6M | 21.7M | 62.3M | 98.1M | 112.9M | 118.5M | |
Non Current Liabilities Total | 2.7M | 1.2M | 325K | 6.2M | 7.2M | 7.5M | |
Inventory | 8.0M | 8.8M | 15.1M | 23.9M | 27.5M | 28.9M | |
Other Current Assets | 512K | 551K | 613K | 621K | 558.9K | 861.9K | |
Other Stockholder Equity | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 154.3M | |
Total Liab | 6.5M | 10.2M | 11.3M | 22.5M | 25.9M | 27.2M | |
Property Plant And Equipment Gross | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Total Current Assets | 17.7M | 19.2M | 60.0M | 89.0M | 102.4M | 107.5M | |
Accumulated Other Comprehensive Income | 2.2M | (28K) | (105K) | (155K) | (178.3K) | (169.3K) | |
Current Deferred Revenue | 170K | 189K | 2.4M | 2.8M | 3.2M | 3.4M | |
Common Stock Total Equity | 221K | 227K | 231K | 237K | 272.6K | 286.2K | |
Common Stock | 231K | 237K | 271K | 285K | 327.8K | 344.1K | |
Other Liab | 22K | 148K | 113K | 72K | 64.8K | 61.6K | |
Other Assets | 153K | 198K | 201K | 231K | 207.9K | 380.5K | |
Property Plant Equipment | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Tangible Assets | 14.1M | 11.4M | 51.0M | 75.6M | 86.9M | 91.3M | |
Retained Earnings Total Equity | (66.2M) | (71.5M) | (74.3M) | (76.3M) | (68.7M) | (72.1M) | |
Capital Surpluse | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 85.6M | |
Deferred Long Term Liab | 522K | 342K | 22K | 99K | 113.9K | 173.1K |
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Aehr Stock
0.75 | MX | MagnaChip Semiconductor Financial Report 1st of May 2024 | PairCorr |
0.71 | ICG | Intchains Group Tech Boost | PairCorr |
0.77 | INTC | Intel Earnings Call Tomorrow | PairCorr |
Moving against Aehr Stock
0.82 | GDDY | Godaddy Financial Report 2nd of May 2024 | PairCorr |
0.43 | MSFT | Microsoft Earnings Call Tomorrow | PairCorr |
0.41 | SQ | Block Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Aehr Test Systems information on this page should be used as a complementary analysis to other Aehr Test's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Aehr Stock analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Aehr Test's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aehr Test. If investors know Aehr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aehr Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.538 | Earnings Share 0.52 | Revenue Per Share 2.506 | Quarterly Revenue Growth (0.56) | Return On Assets 0.0885 |
The market value of Aehr Test Systems is measured differently than its book value, which is the value of Aehr that is recorded on the company's balance sheet. Investors also form their own opinion of Aehr Test's value that differs from its market value or its book value, called intrinsic value, which is Aehr Test's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aehr Test's market value can be influenced by many factors that don't directly affect Aehr Test's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aehr Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aehr Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aehr Test's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.